36 related articles for article (PubMed ID: 32429635)
1. Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients.
Markalunas EG; Arnold DH; Funkhouser AT; Martin JC; Shtutman M; Edenfield WJ; Blenda AV
Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927753
[TBL] [Abstract][Full Text] [Related]
2. Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.
Ma X; Guo W; Yang S; Zhu X; Xiang J; Li H
Dis Markers; 2015; 2015():814670. PubMed ID: 26265795
[TBL] [Abstract][Full Text] [Related]
3. A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis.
Umu SU; Langseth H; Keller A; Meese E; Helland Å; Lyle R; Rounge TB
Mol Oncol; 2020 Feb; 14(2):235-247. PubMed ID: 31851411
[TBL] [Abstract][Full Text] [Related]
4. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer.
Funkhouser A; Shuster H; Martin JC; Edenfield WJ; Blenda AV
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568625
[TBL] [Abstract][Full Text] [Related]
5. The expression level of fibroblast growth factor gene in serum samples of lung cancer patients.
Bu S; Zhang W; Chen X; Liu L; Pang F; Zhou L
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):150-154. PubMed ID: 38279457
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.
Shuster H; Funkhouser A; Allen L; Heo M; Martin JC; Edenfield WJ; Blenda AV
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539500
[TBL] [Abstract][Full Text] [Related]
7. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
Laderach DJ; Compagno D
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572756
[TBL] [Abstract][Full Text] [Related]
8. A distinctive role for galectin-7 in cancer ?
St-Pierre Y; Campion CG; Grosset AA
Front Biosci (Landmark Ed); 2012 Jan; 17(2):438-50. PubMed ID: 22201754
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases.
Hara A; Niwa M; Noguchi K; Kanayama T; Niwa A; Matsuo M; Hatano Y; Tomita H
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32138174
[TBL] [Abstract][Full Text] [Related]
10. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
Qi D; Zhang Y; Li H; Wang R; Qian K
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer].
Liu Z; Xu S; Xiao N; Song C; Zhang H; Li F
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):795-802. PubMed ID: 20704821
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Clinical Significance of Lipocalin-2 in the Serum of Lung Cancer Patients].
Fan L; Tian Y; Sun Y; Hu Z
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):108-111. PubMed ID: 33626852
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
